4.7 Article

Chromone, a Privileged Scaffold for the Development of Monoamine Oxidase Inhibitors

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 54, Issue 14, Pages 5165-5173

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm2004267

Keywords

-

Funding

  1. Foundation for Science and Technology (FCT), Portugal [PTDC/QUI/70359/2006, PTDC/QUI-QUI/113687/2009]
  2. FCT [SFRH/BD/43531/2008, SFRH/BSAB/1090/2010]
  3. Fundação para a Ciência e a Tecnologia [SFRH/BSAB/1090/2010] Funding Source: FCT

Ask authors/readers for more resources

Two series of novel chromone derivatives were synthesized and investigated for their ability to inhibit the activity of monoamine oxidase. The SAR data indicate that chromone derivatives with substituents in position 3 of gamma-pyrone nucleus act preferably as MAO-B inhibitors, with IC50 values in the nanomolar to micromolar range. Almost all chromone 3-carboxamides display selectivity toward MAO-B. Identical substitutions on position 2 of gamma-pyrone nucleus result in complete loss of activity in both isoforms (chromones 2-12 except 3 and 5). Notably, chromone (19) exhibits an MAO-B IC50 of 63 nM, greater than 1000-fold selectivity over MAO-A, and behaves as a quasi-reversible inhibitor. Docking experiments onto the MAO binding of the most active compound highlight different interaction patterns among the isoforms A and B. The differential analysis of the solvation effects among the chromone isomers gave additional insight about the superior outline of the 3-substituted chromone derivatives.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available